Literature DB >> 20976861

Rheumatoid arthritis: time to give up on chemokine receptor antagonism for RA therapy?

Negin Nassabeh.   

Abstract

Entities:  

Year:  2010        PMID： 20976861     DOI： 10.1038/nrrheum.2009.273

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.

Authors:  Clarissa E Vergunst; Danielle M Gerlag; Lisa von Moltke; Michael Karol; Tim Wyant; Xuedong Chi; Ellen Matzkin; Timothy Leach; Paul P Tak
Journal:  Arthritis Rheum       Date:  2009-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.